Skip to Main Content
Welcome to the Scientist.com Marketplace

  1. Home
  2. Blog
  3. Maria Thompson
Go to Main Navigation

Maria Thompson

Maria Thompson, PhD has a background in molecular genetics and over 16 years of experience in pharmaceutical and diagnostics research and development. She has held a variety of roles including Head of Genome Wide Screening for Type 2 diabetes, Six Sigma Black Belt, and VP of Scientific Affairs. Dr. Thompson is a Principal Consultant at APEX Think, a private consulting company providing scientific and technical advisory services to clients across the life science industry. Dr. Thompson holds a BSc in Genetics and a PhD in Molecular and Cellular Biochemistry from the Royal London School of Medicine, UK.
Zeige posts 61-70 von 110 gesamt
May 7, 2013
The World’s Largest Garage Laboratory

The San Diego Business Journal recently interviewed Scientist’s CEO Kevin Lustig about his latest side venture: “Bio, Tech and Beyond”, which is a...

May 2, 2013
3 Barriers to Innovation for Outsourcing Drug Discovery

We work with researchers from big and large pharma to discover new CROs and outsource drug discovery. Whether they have worked with a handful of...

Apr 30, 2013
Drug Development Costs: What Gives?

As previously discussed, drug development costs have been rising to almost prohibitive levels. In 1975, the average approved drug cost $100 million...

Apr 24, 2013
Nearsourcing’s Effect on Vendor Relationships

Outsourcing a project is often seen as an all or nothing proposition: either an entire project is outsourced or everything is kept in house. The...

Apr 18, 2013
How to Nearsource Science Effectively

You’ve made the decision to outsource to a contract research organization, but you’re not sure where to start. Do you send it overseas for lower...

Apr 18, 2013
How “Just Outsourcing” Drives Innovation

We found this on twitter today. It appears @mrgunn doesn’t really grasp the bigger picture of what we do if he thinks of @scientist_com as “just...

Apr 16, 2013
Drug Discovery: Targeting the Epigenome

The health and behavior of each one of our cells is influenced by both genetics and epigenetics. Drug discovery has historically targeted proteins...

Apr 11, 2013
Top 3 Communities for Pharmaceutical Near Sourcing

We’ve established that near sourcing has its advantages over outsourcing, but what are the best areas to near source? CROs, biotechs, and pharmas...

Apr 9, 2013
Drug Discovery: Target Based Versus Phenotypic Screening

What is the most successful preclinical strategy for drug discovery? Finding the answer to this question is important if pharma is to keep its...

Apr 4, 2013
6 Ways Near Sourcing Helps the Life Sciences

Outsourcing is frequently associated with overseas work, however it encompasses all work that you are sending outside the company,including work to...